Royalty Pharma plc - Ordinary Shares - Class A

Description

Royalty Pharma Plc provides drug development services. The firm operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J�s Imbruvica, Astellas and Pfizer�s Xtandi, Biogen�s Tysabri, Gilead�s HIV franchise, Merck�s Januvia, Novartis� Promacta, Vertex�s Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.